Search Results - "I. V. Maev"

Refine Results
  1. 1

    Rebamipide: evidence base for use in gastroenterology by Andreev, D N, Maev, I V

    Published in Terapevtic̆eskii arhiv (15-12-2020)
    “…Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most…”
    Get full text
    Journal Article
  2. 2

    Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis by Kucheryavyy, Y A, Andreev, D N, Maev, I V

    Published in Terapevtic̆eskii arhiv (15-12-2020)
    “…Systematization of data on the frequency of detection of the syndrome of bacterial overgrowth in the small intestine (SIBO) in patients with functional…”
    Get full text
    Journal Article
  3. 3

    Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice by Andreev, D N, Dicheva, D T, Maev, I V

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…A steady decline in the effectiveness of standard eradication therapy (ET) regimens for Helicobacter pylori infection necessitates a search for ways of their…”
    Get full text
    Journal Article
  4. 4

    The prevalence of sarcopenia in patients with chronic pancreatitis: a meta-analysis by Maev, I V, Andreev, D N, Kucheryavyy, Y A, Levchenko, A I

    Published in Terapevtic̆eskii arhiv (15-12-2020)
    “…Systematization of data on the prevalence of sarcopenia in patients with chronic pancreatitis (CP). MEDLINE/PubMed, EMBASE, Cochrane, the Russian Science…”
    Get full text
    Journal Article
  5. 5

    Efficacy of butyric acid inclusion in eradication regimens for Helicobacter pylori infection: a meta-analysis of controlled trials by Andreev, D N, Kucheryavyy, Y A, Maev, I V

    Published in Terapevtic̆eskii arhiv (15-02-2021)
    “…Systematization of data on the efficacy and safety of butyric acid inclusion in eradication therapy (ET) regimens for Helicobacter pylori infection. Research…”
    Get full text
    Journal Article
  6. 6

    Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy by Maev, I V, Andreev, D N

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…In current clinical practice, there is no optimal empirical therapy for Helicobacter pylori (H. pylori) infection and there is a progressive decrease in the…”
    Get full text
    Journal Article
  7. 7

    Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection by Maev, I V, Andreev, D N, Kucheryavyy, Yu A, Shaburov, R I

    Published in Terapevtic̆eskii arhiv (15-08-2019)
    “…Gastroesophageal reflux disease (GERD) is characterized by high morbidity and a significant decrease in the quality of life of patients, and is a major risk…”
    Get full text
    Journal Article
  8. 8

    Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C by Maev, I. V., Kuznetsova, E. I., Andreev, D. N., Dicheva, D. T.

    Published in Terapevtic̆eskii arhiv (27-04-2020)
    “…Aim.Assessment of the diagnostic accuracy of predictive indexes of liver fibrosis for the identification of severe fibrosis and cirrhosis (F3F4) in patients…”
    Get full text
    Journal Article
  9. 9

    Novel coronavirus infection COVID-19: extrapulmonary manifestations by Maev, I V, Shpektor, A V, Vasilyeva, E Y, Manchurov, V N, Andreev, D N

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…The novel coronavirus infection COVID-19 in most cases manifests with respiratory symptoms and fever, however, some patients may have cardiovascular and…”
    Get full text
    Journal Article
  10. 10

    Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study by Andreev, D N, Maev, I V, Dicheva, D T, Samsonov, A A, Partzvania-Vinogradova, E V

    Published in Terapevtic̆eskii arhiv (27-08-2018)
    “…To evaluate the effectiveness and safety of the use of rebamipide as part of the triple eradication therapy (ET) scheme of Helicobacter pylori infection. A…”
    Get full text
    Journal Article
  11. 11

    Development of the Russian version of quality of life questionnaire in patients with GERD - GERD-HRQL by Ionova, T I, Nikitina, T P, Mayevskaya, E A, Cheremushkina, N V, Shaburov, R I, Kucheryavyy, Y A, Maev, I V

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…Gastroesophageal reflux disease (GERD) is a common chronic disease of the upper gastrointestinal tract with long course of the disease and followed by…”
    Get full text
    Journal Article
  12. 12

    The cardiovascular system in patients with functional and inflammatory bowel diseases by Maev, I V, Kazulin, A N, Andreev, D N

    Published in Terapevtic̆eskii arhiv (15-02-2018)
    “…Identification of subclinical and metamanifests state changes of cardiovascular system in patients with functional and inflammatory bow- el diseases (IBD)…”
    Get full text
    Journal Article
  13. 13

    Testing and validation of the Russian version of quality of life questionnaire in patients with GERD - GERD-HRQL by Ionova, T I, Zinkovskaya, A V, Mayevskaya, E A, Nikitina, T P, Porfirieva, N M, Cheremushkina, N V, Shaburov, R I, Kucheryavyy, Y A, Maev, I V

    Published in Terapevtic̆eskii arhiv (15-12-2020)
    “…This study aimed to test the Russian version of GERD-HRQL in the focus group of patients with GERD, as well as to evaluate its psychometric properties…”
    Get full text
    Journal Article
  14. 14

    Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease by Maev, I V, Barkalova, E V, Ovsepyan, M A, Kucheryavyi, Yu A, Andreev, D N

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…Gastroesophageal reflux disease (GERD) is a common condition that has a substantial impact on quality of life in patients and is a leading risk factor for…”
    Get full text
    Journal Article
  15. 15

    Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease by Ivashkin, V T, Maev, I V, Trukhmanov, A S, Rumyantseva, D E

    Published in Terapevtic̆eskii arhiv (27-08-2018)
    “…Purpose of the review to present up-to-date data on the causes, methods of diagnosis and treatment of the refractory form of gastroesophageal reflux disease…”
    Get full text
    Journal Article
  16. 16

    Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results by Maev, I V, Andreev, D N, Govorun, V M, Ilina, E N, Kucheryavyy, Y A, Oganesian, T S, Melnikova, E V, Zayratyants, O V, Parfenova, T V, Dzhedzheia, L V, Kirillova, N V, Maevskaya, E A, Fomenko, A K, Lobanova, E G, Zaborovskii, A V, Kriukov, K A

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian…”
    Get full text
    Journal Article
  17. 17

    Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations by Maev, I V, Bideeva, Т В, Kucheryavyy, Yu A, Andreev, D N, Bueverov, A O

    Published in Terapevtic̆eskii arhiv (27-08-2018)
    “…The article reflects the main positions of the latest Russian and pan-European clinical recommendations on the diagnosis and treatment of chronic pancreatitis…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Features of the functional activity of macrophage link of immunity with gastroesophageal reflux disease depending on the type of reluctate: in vitro model by Lyamina, S V, Maev, I V, Kalish, S V, Andreev, D N, Kladovikova, O V, Malyshev, I Yu

    Published in Terapevtic̆eskii arhiv (15-02-2018)
    “…A generalized analysis of changes in functional activity of macrophages on the basis of phagocytic activity, cytokine profile, changes in the level of…”
    Get full text
    Journal Article
  20. 20

    Nutritional status in patients with chronic pancreatitis by Maev, I V, Kucheryavyi, Yu A, Andreev, D N, Bideeva, T V

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…Chronic pancreatitis (CP) is an inflammatory disease of the pancreas, accompanied by damage to the functioning parenchyma and ducts to develop irreversible…”
    Get full text
    Journal Article